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Introduction 
The strong national commitment to excellence in health care 
requires resources and personnel that far exceed those that 
are available. Therefore, numerous decisions must be made 
regarding priorities and resource utilization. The medical 
profession must participate in these determinations, includ- 
ing the examination of the impact of developing technology 
on the practice and cost of medical care. Such analyses, 
carefully conducted, could potentially influence the expen- 
ditures and the effectiveness of medical care. 
The following information provides a guide to the physi- 
cian qualifications needed to perform peripheral vascular 
interventions, particularly angioplasty, with attention di- 
rected toward physician skill development (during training 
or postgraduate study), the radiclogic facitities required to 
perform interventional procedures and the establishment of 
a hospital-based registry to permit peer review. 
To this end, the American College of Cardiology as welt 
as olher organizations such as the American Heart Associ- 
ation, the Society for Cardiac Angiography and Intervention 
and the Society of Cardiovascular and Interver$ional Radi- 
ology established, in 1989. subcomminees on peripheral 
vascular disease and peripheral vascular interventions to 
address some of these concerns. 
Training and Credentlaling 
Cardiovascular interventional techniques require special- 
ized skills and training in diagnostic angiographic as well as 
diagnostic and therapeutic cardiovascular medicine. Al- 
though the majority of individuals currently performing 
angioplasty learned the technique by observing experts. 
participating in individual tutorials and attending “how-to” 
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seminars, the complexity of the procedures and the recog- 
nized need for hands-on experience dictate that formal 
training programs in peripheral angioplasty and other vascu- 
lar interventions become the standard means of learning. 
Entrance requirements to such programs should require the 
completion of a structured cardiovascular (cardiology) or 
radiology fellowship program. Alternatively, formal training 
should he part of a vascular surgery residence program 
entered after hoard certification in general surgery, or a 
vascular medicine fellowship program entered after board 
certification in internal medicine. 
A growing conseasus within the cardiovascular medicine 
community suggests that the performance of peripheml 
angiaplasty requires the individual to takeadditional instruc- 
tion that includes the natural history of and the anatomic 
changes occurring with vascu!ar disease, noninvasive pa- 
tient assessment, the indications for and risks and benefits of 
different therapeutic modalities (including conservative mea- 
sures, angioplasty, surgical techniques, other interventional 
techniques and the indications for the use of and manage- 
menc of thrombolytic agents). 
A desirable experience for a single physic& to demon- 
strate and maintain competence and proficiency is estimated 
to be about one case/week with continued performance 
dependent on the success and complication rates compiled 
by a hospital data registry and compared biannually with 
expected standards. Regular attendance at postgraduate 
seminars would provide continuing education in nerH endo- 
vascular techniques and equipment. 
Responsible leadership of health care institutions offering 
peripheral angioplasty as part of their health care program 
should insist on the documentation ofaccredited training and 
maintenance of physician skills. The practice of peripheral 
angioplasty by the untrained physician should be avoided; it 
is risky and contrary to patient welfare and good medical 
practice. 
A training program chiefs written assurance that a phy- 
sician has learned a procedure during the training phase 
provides the requisite information for the credentlaling com- 
mittee to grant the appropriate type of privileges (i.e.. 
probational, temporary and. subsequently. regular [renew- 
able] full privileges), a siluation that differs for a new 
procedure once a physician has cumpieled his or her focal 
training. As variaus specialties merge, and as different 
modalides ofdiagnosis or therapy develop, individual phy- 
sicians must be able to study and utilize these new modalities 
for better patient care. Therefore, there should be muluple 
tracks to enable physicians to obtain these privileges at 
various tages in their career. 
Suggested guidelines for the performance of percutane- 
ous transluminal angigplasty and related inlerventional pro- 
cedures arc: 
1. Physician Quaiifieations. 
1. Physicians hould have accomplished the fol- 
lowing to obtain peripheral angioplasty privi- 
leges: 
a. The physician-in-training (in a formal fellow- 
ship program) should provide the hospital 
with a list of patients, including the total 
number of cases he or she attended and!or 
served as primary operator. the sites (le- 
sions) treated and the complications encoun- 
tered. This information should be accompa- 
nied by a letter fmm the progr,a~ director 
stating that the physician was adequately 
trained and should be capable of performing 
peripheral angioplzty indeperdently. A 
physician who does not meet hese require- 
ments hould enter the postgraduate s ctiun 
(1, lb) 
i. Angiographic experience: A desired num- 
ber of 100 diagnostic peripheral angio- 
grams and 50 peripheral angioplasty pro- 
cedures should have been performed 
under the supervision of an experienced 
peripheral interventionist (with >5070 
performed as primary operator). The phy- 
sician should also have had experiences 
in 10 cases of peripheral thrombolytic 
therapy and management. 
b. Postgraduate physicians with or without 
prior peripheral angiographic experience 
and without previous peripheral angioplasty 
experience should have: 
i. Attended at least two peripheral angio- 
plasty seminars, including one with live 
case demonstrations; learned the nature 
of and anatomy of peripheral vascular 
disease and its natural history. the iridica- 
tions for and risks and beneIits of alter- 
native therapies; learned to perform non- 
invasive patient evaluation; visited a 
laboratory in which peripheral angio- 
11. 
plasty was actively being performed by 
experienced personnel; and observed an 
least IO peripheral angioplasty proce- 
dures. 
ii. Angingraphic experience: A desired num- 
ber of 100 diagnostic peripheral angio- 
grams and 50 peripheral angioplasty pro- 
cedures should have been performed 
under the supervision of an experienced 
peripheral interventionist (with >50% 
performed as primary operator). The phy- 
sician should also have had experience in
IO cases of peripheral thrombolytic ther- 
apy management. 
Suggested Recommendations for Peripheral Vas- 
cular Intervention Patient Registry (Quality As- 
surance). 
Maintenance of peripheral angioplasty privi- 
leges could be dependent on the physician‘s active 
participation i a Saint Commission on Accredita- 
tion of Health Care Organizations-mandated qurd- 
ity asstn-mce program. 
A hospital peripheral angioplasty and vascular 
intervmtion data registry. its costs borne by the 
hospital. should be established to: 
I. Enroll all patients who undergo peripheral an- 
gioplasty and other peripheral interventions. 
2. Compile statistics from a data base form ittclud- 
ing data on clinical characteristics. pertinent 
medical and surgical history and appropriate 
medical examination tindings. 
3. Record angioplasty data ir;doz!iy iticmmtion 
on angioplasty site. angiographic and clinical 
success. transstenoticlocclusion. pressure mea- 
surements and procedural compl&ions (e.g., 
renal failure, stroke, bleeding problems, entry 
site repair, emergency bypass urgery, death). 
Obtain clinical follow-up (by telephone, letter, 
interview. office visit) after hospital discharge 
at 1 week, 3 months and 1 year. 
AIt cases must be entered into the peripheral 
angioplasty vascular intervention data registry 
and the data reviewed on an annual or biannual 
basis by a peer review panel. This panel should 
forward its observations to the section, depalt- 
ment or hospital committee. These data should 
be reviewed, with physicians listed by a code 
known only to the director of the registry. If the 
results are acceptabte. then credentials and 
privileges hould be reviewed and renewed on a 
biannual basis. 
4. 
5. 
II:. Minimal Requirements for Radiologic Facilities 
for Peripheral Angioplasty. 
The resources for cardiac catheterizariun a d 
radiographic facilities have been detailed in Fries- 
inger GC. et al. “Optimal Resources for Exami- 
nation of The Heart and Lungs: Cardiac Catheter- 
ization and Radiographic Facilities” (Circularion 
1983;68:893A-93OA), which presented guidelines 
for administration, space, equipment, personnel 
and working arrangements for diagnostic cardio- 
vascular laboratories. These recommendations 
apply to any laboratory planning to perform pe- 
ripheral angioplasty procedures. 
in addition, a laboratory performing peripheral 
angioplasty should have available the following: 
1. An ample inventory of balloon dilation cathe- 
ters, cahbrated balloon inflation devices and a 
complete range of existing guide wires of vari- 
able flexibility and steerability. 
2. A hiah resolution flooroscooic svstem and an . , 
optimal television chain that allows ready visu- 
a!ization of a 0.014”in. (0.036 cm) guide wire 
and in which still frames or “road map images” 
can be displayed simultaneously with the real 
time !luoroscopic image. 
3. Preferably, an angulatlng X-ray tube image 
intensifier arm that allows ready three- 
dimensional determination of the anatomic po- 
sition of a guide wire or balloon catheter. 
4. A physiologic recording system, a high resolu- 
tion fluoroscope, cineangiographic and/or digi- 
tal (subtruction or acquisition) angiograpbic 
and/or cut film (analog) angiographic equip- 
ment, a complete set of emergency resuscita- 
tion instruments and a full complement of 
“rugs. 
5. Radiation exposure control systems .nrluding 
such items as an X-ray beam with automatic 
collimation, a carbon fiber scattered radiation 
grid, carbon fiber tabletop and a correct tube 
filter. Further reduction of radiation exposure 
to personnel can be achieved by gap filling 
during cinematography, using a reference mon- 
itor for pathfinding and video disks for auto- 
matic storage and replay. All personnel should 
be further protected from radiation exposure by 
the use of appropriate lead aprons, eyeglasses, 
thyroid protection and additional shielding of 
the X-ray tube 
Diagnostic imagingjne resolution: Diagnostic 
imaging ideally should be obtained by using 
contrast material and imaging of the entire 
vascular distribution in question using conven- 
tional analog film changers or adequate field 
digital or analogies imaging systems. For exam- 
ple. peripheral angiography of vessels should 
image the vessels of both lower limbs from the 
distal abdominal aorta down to the distal leg. 
The use of video fluoroscopy alone is not 
suficient to perform diagnostic peripheral an- 
giogmphic studies. This procedure may be per- 
formed on an outpatient or inpatient basis. 
The specific requisite space, eqllipment, per- 
sonnel and administration of an appropriate 
vascular surgery operating suite falls outside 
these recommendations but should include a 
surgical operating suite that is equipped lo 
provide general anesthesia, a full complement 
of instruments for peripheral vascular surgery, 
as well as drugs for management of the cardio- 
vascular patient. 
Appendix: Definitions 
1. An&graphic success = ~30% residual diameter steno- 
SW 
2. Clinical success = angiographic success of culprit lesion 
or lesions and clinical improvement. 
